Abstract
A six year randomised trial was conducted among 5139 apparently healthy male doctors to see whether 500 mg aspirin daily would reduce the incidence of and mortality from stroke, myocardial infarction, or other vascular conditions. Though total mortality was 10% lower in the treated than control group, this difference was not statistically significant and chiefly involved diseases other than stroke or myocardial infarction. Likewise, there was no significant difference in the incidence of non-fatal myocardial infarction or stroke—indeed, disabling strokes were somewhat commoner among those allocated aspirin. The lower confidence limit for the effect of aspirin on non-fatal stroke or myocardial infarction, however, was a substantial 25% reduction. Migraine and certain types of musculoskeletal pain were reported significantly less often in the treated than control group, but as the control group was not given a placebo the relevance of these findings was difficult to assess. There was no apparent reduction in the incidence of cataract in the treated group.
The lack of any apparent reduction in disabling stroke or vascular death contrasts with the established value of antiplatelet treatment after occlusive vascular disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gerrity T. R., Cotromanes E., Garrard C. S., Yeates D. B., Lourenço R. V. The effect of aspirin on lung mucociliary clearance. N Engl J Med. 1983 Jan 20;308(3):139–141. doi: 10.1056/NEJM198301203080306. [DOI] [PubMed] [Google Scholar]
- Kewitz H., Nitz M., Gaus V. Aspirin and cataract. Lancet. 1986 Sep 20;2(8508):689–689. doi: 10.1016/s0140-6736(86)90197-2. [DOI] [PubMed] [Google Scholar]
- O'Neill B. P., Mann J. D. Aspirin prophylaxis in migraine. Lancet. 1978 Dec 2;2(8101):1179–1181. doi: 10.1016/s0140-6736(78)92159-1. [DOI] [PubMed] [Google Scholar]
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Heyningen R., Harding J. J. Do aspirin-like analgesics protect against cataract? A case-control study. Lancet. 1986 May 17;1(8490):1111–1113. doi: 10.1016/s0140-6736(86)91834-9. [DOI] [PubMed] [Google Scholar]